230 related articles for article (PubMed ID: 22949736)
1. Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain.
Robinson JW; Potter LR
Sci Signal; 2012 Sep; 5(240):ra65. PubMed ID: 22949736
[TBL] [Abstract][Full Text] [Related]
2. The pseudokinase domains of guanylyl cyclase-A and -B allosterically increase the affinity of their catalytic domains for substrate.
Edmund AB; Walseth TF; Levinson NM; Potter LR
Sci Signal; 2019 Jan; 12(566):. PubMed ID: 30696704
[TBL] [Abstract][Full Text] [Related]
3. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP.
Dickey DM; Otto NM; Potter LR
J Biol Chem; 2017 Jun; 292(24):10220-10229. PubMed ID: 28450398
[TBL] [Abstract][Full Text] [Related]
4. ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.
Robinson JW; Potter LR
J Biol Chem; 2011 Sep; 286(39):33841-4. PubMed ID: 21828054
[TBL] [Abstract][Full Text] [Related]
5. Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP.
Antos LK; Potter LR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1756-63. PubMed ID: 17848634
[TBL] [Abstract][Full Text] [Related]
6. ATP allosteric activation of atrial natriuretic factor receptor guanylate cyclase.
Duda T; Yadav P; Sharma RK
FEBS J; 2010 Jun; 277(11):2550-3. PubMed ID: 20553491
[TBL] [Abstract][Full Text] [Related]
7. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
Khurana ML; Pandey KN
Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
[TBL] [Abstract][Full Text] [Related]
8. Discovery of small molecule guanylyl cyclase A receptor positive allosteric modulators.
Sangaralingham SJ; Whig K; Peddibhotla S; Kirby RJ; Sessions HE; Maloney PR; Hershberger PM; Mose-Yates H; Hood BL; Vasile S; Pan S; Zheng Y; Malany S; Burnett JC
Proc Natl Acad Sci U S A; 2021 Dec; 118(52):. PubMed ID: 34930837
[TBL] [Abstract][Full Text] [Related]
9. Allosteric modification, the primary ATP activation mechanism of atrial natriuretic factor receptor guanylate cyclase.
Duda T; Yadav P; Sharma RK
Biochemistry; 2011 Feb; 50(7):1213-25. PubMed ID: 21222471
[TBL] [Abstract][Full Text] [Related]
10. Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor.
Beste KY; Spangler CM; Burhenne H; Koch KW; Shen Y; Tang WJ; Kaever V; Seifert R
PLoS One; 2013; 8(7):e70223. PubMed ID: 23922959
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor receptor guanylate cyclase signaling: new ATP-regulated transduction motif.
Duda T; Bharill S; Wojtas I; Yadav P; Gryczynski I; Gryczynski Z; Sharma RK
Mol Cell Biochem; 2009 Apr; 324(1-2):39-53. PubMed ID: 19137266
[TBL] [Abstract][Full Text] [Related]
12. A disulfide-bridged mutant of natriuretic peptide receptor-A displays constitutive activity. Role of receptor dimerization in signal transduction.
Labrecque J; Mc Nicoll N; Marquis M; De Léan A
J Biol Chem; 1999 Apr; 274(14):9752-9. PubMed ID: 10092664
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and pharmacological characterization of P-site inhibitors on homodimeric guanylyl cyclase domain from natriuretic peptide receptor-A.
Joubert S; McNicoll N; De Léan A
Biochem Pharmacol; 2007 Apr; 73(7):954-63. PubMed ID: 17196175
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for the activation of Escherichia coli CTP synthase by the allosteric effector GTP are stringent, but requirements for inhibition are lax.
Lunn FA; MacDonnell JE; Bearne SL
J Biol Chem; 2008 Jan; 283(4):2010-20. PubMed ID: 18003612
[TBL] [Abstract][Full Text] [Related]
15. Three dimensional atomic model and experimental validation for the ATP-Regulated Module (ARM) of the atrial natriuretic factor receptor guanylate cyclase.
Duda T; Yadav P; Jankowska A; Venkataraman V; Sharma RK
Mol Cell Biochem; 2001 Jan; 217(1-2):165-72. PubMed ID: 11269661
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide-dependent photolabeling of a regulatory ATP-binding site on the natriuretic peptide receptor-A.
Joubert S; Jossart C; McNicoll N; De Léan A
FEBS J; 2005 Nov; 272(21):5572-83. PubMed ID: 16262696
[TBL] [Abstract][Full Text] [Related]
17. Distinct inhibitory ATP-regulated modulatory domain (ARMi) in membrane guanylate cyclases.
Duda T; Goraczniak R; Sharma RK
Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):279-83. PubMed ID: 8870679
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors.
van den Akker F
J Mol Biol; 2001 Aug; 311(5):923-37. PubMed ID: 11556325
[TBL] [Abstract][Full Text] [Related]
19. The guanylyl cyclase core of an atrial natriuretic peptide receptor: enzymatic properties and basis for cooperativity.
Thorpe DS; Niu S; Morkin E
Biochem Biophys Res Commun; 1996 Jan; 218(3):670-3. PubMed ID: 8579572
[TBL] [Abstract][Full Text] [Related]
20. Homologous desensitization of guanylyl cyclase A, the receptor for atrial natriuretic peptide, is associated with a complex phosphorylation pattern.
Schröter J; Zahedi RP; Hartmann M; Gassner B; Gazinski A; Waschke J; Sickmann A; Kuhn M
FEBS J; 2010 Jun; 277(11):2440-53. PubMed ID: 20456499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
